Repligen Corporation
RGEN
$157.39
-$4.27-2.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 707.89M | 673.96M | 650.43M | 634.44M | 633.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 707.89M | 673.96M | 650.43M | 634.44M | 633.51M |
| Cost of Revenue | 342.70M | 330.31M | 317.73M | 315.77M | 308.99M |
| Gross Profit | 365.19M | 343.65M | 332.70M | 318.67M | 324.52M |
| SG&A Expenses | 250.80M | 251.08M | 246.98M | 238.28M | 257.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 645.43M | 628.85M | 608.50M | 596.79M | 607.82M |
| Operating Income | 62.46M | 45.10M | 41.93M | 37.65M | 25.69M |
| Income Before Tax | 4.66M | -13.60M | -22.79M | -27.04M | 13.44M |
| Income Tax Expenses | 2.92M | 228.00K | 193.00K | -1.52M | 21.53M |
| Earnings from Continuing Operations | 1.74 | -13.83 | -22.98 | -25.51 | -8.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.74M | -13.83M | -22.98M | -25.51M | -8.10M |
| EBIT | 62.46M | 45.10M | 41.93M | 37.65M | 25.69M |
| EBITDA | 139.62M | 119.66M | 113.39M | 107.30M | 94.24M |
| EPS Basic | 0.03 | -0.25 | -0.41 | -0.45 | -0.15 |
| Normalized Basic EPS | 0.74 | 0.61 | 0.57 | 0.51 | 0.45 |
| EPS Diluted | 0.01 | -0.26 | -0.42 | -0.46 | -0.15 |
| Normalized Diluted EPS | 0.74 | 0.61 | 0.57 | 0.51 | 0.45 |
| Average Basic Shares Outstanding | 224.68M | 224.43M | 224.08M | 223.74M | 223.50M |
| Average Diluted Shares Outstanding | 225.66M | 225.14M | 225.06M | 225.03M | 224.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |